Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. [electronic resource]
- Carcinogenesis Feb 2013
- 475-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't